Welcome to the world of immunohistochemistry!
📞 800-8581156 📧 info@naim.com.cn
Menu
  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Close
分类
  • Consultation and Feedback
  • Hotspot Focus
  • Immunohistochemistry and Pathology
  • Immunohistochemistry Technology Exchange
  • Industry News
  • Maxxin Dynamics
  • Meeting Notice
  • News and Information
  • Public laboratory
  • Recommended List and Introduction of Newly Developed IHC
  • Service and Support
  • Uncategorized
Product Search
06 2 月

2016 Group-based Academic Conference Series for Tibet Aid and the First Qinghai-Tibet Pathology Academic Exchange and Technical Training Conference Successfully Held in Lhasa!

Continue reading
06 2 月

Maxin Biotech and PreciThera Forge Strategic Partnership to Boost Innovative Drug R&D Across Multiple Dimensions!

Continue reading
06 2 月

Pepsinogen I and H+/K+ ATPase β: Specific Markers for Gastric Fundic Gland Adenocarcinoma

Continue reading
06 2 月

Pathology Weekly Reading Notes Issue 37: Immunohistochemical Markers for Diagnosing Central Nervous System Tumors and Meningiomas

Continue reading
06 2 月

Max2inOneTM Paraffin Section Deparaffinization and Antigen Retrieval System

Continue reading
06 2 月

Week 34 of “Mai Mai” Pathology Reading Notes | Immunohistochemical Markers for the Diagnosis of Muscle Tissue Tumors

Continue reading
06 2 月

2015 Immunohistochemistry Technology Theory and Application Training Successfully Concluded

Continue reading
06 2 月

Farewell Tumor: A Self-Narrative of SMARCA4-Deficient Tumors

Continue reading
06 2 月

Chronic H. pylori Infection Classified as a “Definite Carcinogen”: Maxin’s HP Antibody Aids Scientific Prevention and Control!

Continue reading
06 2 月

Fuzhou Maixin Successfully Holds Product Launch for “PathCom Fully Automated Pathology Staining System”

Continue reading
  • «
  • ‹
  • 34
  • 35
  • 36
  • 37
  • 38
  • ›
  • »

Copyright © 1993 - 2017 Fuzhou Maixin Biotechnology Development Co., Ltd. MinICP No. 05015562-1 | (Fujian) - Non-commercial - 2017-0010

  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Sidebar